Methylation and silencing of the Thrombospondin-1 promoter in human cancer

Qing Li, Nita Ahuja, Peter C. Burger, Jean Pierre J Issa

Research output: Contribution to journalArticle

Abstract

Neovascularization is a common feature of many human cancers, but relatively few molecular defects have been demonstrated in genes regulating angiogenesis. Decreased expression of Thrombospondin-1 (THBS1), a P53 and Rb regulated angiogenesis inhibitor, has been observed in some human tumors, including glioblastoma multiforme (GBM). To study whether methylation-associated inactivation is involved in down-regulating THBS1 expression in cancer, we analysed the methylation status of THBS1 in several cell lines and primary tumors. Three cell lines (RKO, CEM and RAJI) were completely methylated at several CpG sites within the THBS1 5' CpG island, and had no detectable expression by RT-PCR. THBS1 expression was readily reactivated using the methylation-inhibitor 5-deoxy-azacytidine in all three lines. Furthermore, THBS1 methylation was present in 33% (14/42) of primary GBMs. Thus, de novo methylation may serve as a potential way to inactivate THBS1 expression in human neoplasms.

Original languageEnglish (US)
Pages (from-to)3284-3289
Number of pages6
JournalOncogene
Volume18
Issue number21
DOIs
StatePublished - May 27 1999

Fingerprint

Thrombospondin 1
Methylation
Neoplasms
Cartilage Oligomeric Matrix Protein
Azacitidine
CpG Islands
Angiogenesis Inhibitors
Glioblastoma
Tumor Cell Line
Cell Line
Polymerase Chain Reaction

Keywords

  • Angiogenesis
  • DNA methylation
  • Glioblastoma multiforme
  • Thrombospondin-1 (THBS1)

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Methylation and silencing of the Thrombospondin-1 promoter in human cancer. / Li, Qing; Ahuja, Nita; Burger, Peter C.; Issa, Jean Pierre J.

In: Oncogene, Vol. 18, No. 21, 27.05.1999, p. 3284-3289.

Research output: Contribution to journalArticle

Li, Qing ; Ahuja, Nita ; Burger, Peter C. ; Issa, Jean Pierre J. / Methylation and silencing of the Thrombospondin-1 promoter in human cancer. In: Oncogene. 1999 ; Vol. 18, No. 21. pp. 3284-3289.
@article{6650b66d1e6941f885131af56ca40f5b,
title = "Methylation and silencing of the Thrombospondin-1 promoter in human cancer",
abstract = "Neovascularization is a common feature of many human cancers, but relatively few molecular defects have been demonstrated in genes regulating angiogenesis. Decreased expression of Thrombospondin-1 (THBS1), a P53 and Rb regulated angiogenesis inhibitor, has been observed in some human tumors, including glioblastoma multiforme (GBM). To study whether methylation-associated inactivation is involved in down-regulating THBS1 expression in cancer, we analysed the methylation status of THBS1 in several cell lines and primary tumors. Three cell lines (RKO, CEM and RAJI) were completely methylated at several CpG sites within the THBS1 5' CpG island, and had no detectable expression by RT-PCR. THBS1 expression was readily reactivated using the methylation-inhibitor 5-deoxy-azacytidine in all three lines. Furthermore, THBS1 methylation was present in 33{\%} (14/42) of primary GBMs. Thus, de novo methylation may serve as a potential way to inactivate THBS1 expression in human neoplasms.",
keywords = "Angiogenesis, DNA methylation, Glioblastoma multiforme, Thrombospondin-1 (THBS1)",
author = "Qing Li and Nita Ahuja and Burger, {Peter C.} and Issa, {Jean Pierre J}",
year = "1999",
month = "5",
day = "27",
doi = "10.1038/sj.onc.1202663",
language = "English (US)",
volume = "18",
pages = "3284--3289",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "21",

}

TY - JOUR

T1 - Methylation and silencing of the Thrombospondin-1 promoter in human cancer

AU - Li, Qing

AU - Ahuja, Nita

AU - Burger, Peter C.

AU - Issa, Jean Pierre J

PY - 1999/5/27

Y1 - 1999/5/27

N2 - Neovascularization is a common feature of many human cancers, but relatively few molecular defects have been demonstrated in genes regulating angiogenesis. Decreased expression of Thrombospondin-1 (THBS1), a P53 and Rb regulated angiogenesis inhibitor, has been observed in some human tumors, including glioblastoma multiforme (GBM). To study whether methylation-associated inactivation is involved in down-regulating THBS1 expression in cancer, we analysed the methylation status of THBS1 in several cell lines and primary tumors. Three cell lines (RKO, CEM and RAJI) were completely methylated at several CpG sites within the THBS1 5' CpG island, and had no detectable expression by RT-PCR. THBS1 expression was readily reactivated using the methylation-inhibitor 5-deoxy-azacytidine in all three lines. Furthermore, THBS1 methylation was present in 33% (14/42) of primary GBMs. Thus, de novo methylation may serve as a potential way to inactivate THBS1 expression in human neoplasms.

AB - Neovascularization is a common feature of many human cancers, but relatively few molecular defects have been demonstrated in genes regulating angiogenesis. Decreased expression of Thrombospondin-1 (THBS1), a P53 and Rb regulated angiogenesis inhibitor, has been observed in some human tumors, including glioblastoma multiforme (GBM). To study whether methylation-associated inactivation is involved in down-regulating THBS1 expression in cancer, we analysed the methylation status of THBS1 in several cell lines and primary tumors. Three cell lines (RKO, CEM and RAJI) were completely methylated at several CpG sites within the THBS1 5' CpG island, and had no detectable expression by RT-PCR. THBS1 expression was readily reactivated using the methylation-inhibitor 5-deoxy-azacytidine in all three lines. Furthermore, THBS1 methylation was present in 33% (14/42) of primary GBMs. Thus, de novo methylation may serve as a potential way to inactivate THBS1 expression in human neoplasms.

KW - Angiogenesis

KW - DNA methylation

KW - Glioblastoma multiforme

KW - Thrombospondin-1 (THBS1)

UR - http://www.scopus.com/inward/record.url?scp=0033609371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033609371&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202663

DO - 10.1038/sj.onc.1202663

M3 - Article

VL - 18

SP - 3284

EP - 3289

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 21

ER -